Clinical and symptomatological characterization regarding Chagas disease caused by the Trypanosoma cruzi parasite
暂无分享,去创建一个
M. G. Alves | Daniel Lopes Araújo | Mariana Silva Souza | Bruno Abílio da Silva Machado | José Marcos Fernandes Mascarenhas | S. Alves | Lucas Moreno | Maria Leopoldina Mota do Nascimento | Éryca Maria Teixeira da Silva | M. M. Carvalho | Larissa de Lima Machado Bandeira | Natália Rodrigues da Silva | S. M. D. Carvalho | Raimundo Nonato Araujo Vieira Neto | Nágila Iane Pacheco | Luiza Aragão Paiva Pires Ferreira Mendes | Lívia Maria da Silva Gomes | Josemária Chaves Sipaúba Silva | Kaio Germano Sousa da Silva | João Paulo Gomes Oliveira
[1] J. R. Correia,et al. Doença de Chagas: aspectos clínicos, epidemiológicos e fisiopatológicos , 2021 .
[2] Gabriel da Silva Macedo,et al. Revalidação do painel sorológico empregado na avaliação dos kits de diagnóstico da doença de Chagas , 2020 .
[3] J. Altcheh,et al. Adverse Events Associated with Nifurtimox Treatment for Chagas Disease in Children and Adults , 2020, Antimicrobial Agents and Chemotherapy.
[4] João Paulo Toledo,et al. Doenças infecciosas e parasitárias no Brasil de 2010 a 2017: aspectos para vigilância em saúde , 2020, Revista panamericana de salud publica = Pan American journal of public health.
[5] F. Chappuis,et al. Tolerance to nifurtimox and benznidazole in adult patients with chronic Chagas’ disease , 2019, The Journal of antimicrobial chemotherapy.
[6] R. Novaes,et al. An evaluation of benznidazole as a Chagas disease therapeutic , 2019, Expert opinion on pharmacotherapy.
[7] C. Almeida,et al. Morphobiological, morphometric and ultrastructural characterization of sylvatic Trypanosoma cruzi isolates from Rio de Janeiro state, Brazil. , 2019, Brazilian journal of biology = Revista brasleira de biologia.
[8] W. Monteiro,et al. Oral Transmission of Trypanosoma cruzi, Brazilian Amazon , 2019, Emerging infectious diseases.
[9] Andréa Bessa Teixeira,et al. Métodos de diagnóstico para a doença de Chagas: uma atualização , 2019 .
[10] A. Ribeiro,et al. Beneficial effects of benznidazole in Chagas disease: NIH SaMi-Trop cohort study , 2018, PLoS neglected tropical diseases.
[11] E. Kransdorf,et al. Diagnosis and Management of Chagas Cardiomyopathy in the United States , 2018, Current Cardiology Reports.
[12] A. L. R. Roque,et al. Trypanosoma cruzi transmission in the wild and its most important reservoir hosts in Brazil , 2018, Parasites & Vectors.
[13] Eduardo Arrais Rocha,et al. Trypanosoma cruzi seroprevalence among solid organ donors in Ceará State, Brazil. , 2018, Revista da Sociedade Brasileira de Medicina Tropical.
[14] G. Buck,et al. Trypanosoma rangeli is phylogenetically closer to Old World trypanosomes than to Trypanosoma cruzi. , 2018, International journal for parasitology.
[15] E. Dumonteil,et al. Detailed ecological associations of triatomines revealed by metabarcoding and next-generation sequencing: implications for triatomine behavior and Trypanosoma cruzi transmission cycles , 2018, Scientific Reports.
[16] C. Bezerra,et al. Insect vectors of Chagas disease (Trypanosoma cruzi) in Northeastern Brazil. , 2018, Revista da Sociedade Brasileira de Medicina Tropical.
[17] Jadher Percio,et al. Investigação de surto de doença de Chagas aguda na região extra-amazônica, Rio Grande do Norte, Brasil, 2016 , 2018 .
[18] B. Zingales. Trypanosoma cruzi genetic diversity: Something new for something known about Chagas disease manifestations, serodiagnosis and drug sensitivity. , 2017, Acta tropica.
[19] M. Cowie,et al. Heart failure: classification and pathophysiology , 2010, Medicine.
[20] Rejane Seila da Silva Castro. Construção e validação de um manual para diagnóstico de doença de Chagas , 2018 .
[21] R. Tarleton,et al. Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure , 2017, bioRxiv.
[22] D. D. Souza,et al. Aspectos epidemiológicos e clínicos da Doença de Chagas aguda no Brasil e na américa Latina , 2016 .